This immunophenotype is specific in patients with high PBK expression, and a large number of algorithms and data validate that anti-tumor immune cell infiltration is increased but the patient's immune profile remains poor, and secondly that immunosuppressive cells do not play a strong role in the tumor microenvironment. Here, PBK is linked to neoplasm.